Delivery Order SPE2DB24D2018-SPE2DB25FWSK3
Award Date
1/6/25
Potential Completion Date
1/7/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $15,202.26 firm fixed-price contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to treat diabetes. The order has an ultimate completion date of May 22, 2024. This appears to be a call against a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a $7,561.40 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of January 6, 2025 and was awarded on January 3, 2025. This award is part of a larger $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,390.44, is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a prescription medication used to treat type 2 diabetes. The contract is a Firm Fixed Price, Delivery Order, with an ultimate completion date of January 3, 2025. The contract was not set aside for any specific...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,841.38 firm fixed-price delivery order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used for the treatment of diabetes. The contract has an ultimate completion date of December 20, 2024 and was awarded on December 19, 2024. This delivery order is part of a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $11,398.06 fixed-price contract is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The contract has a period of performance through December 31, 2024 and was awarded on December 30, 2024. This award is under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,113.22, is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and a performance period through January 2, 2025. This order is placed under a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to treat diabetes. The award has a ceiling value of $48,446.57 and a period of performance through January 9, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. This contract...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $14,857.40 firm fixed-price contract is for the supply of Ozempic 2 mg/dose (8 mg/3 mL) 3 mL, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of August 28, 2024 and was awarded on August 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,023.85, is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to treat type 2 diabetes. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,785.51 contract is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a specialty medication used for the treatment of diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of December 18, 2024. This delivery order is likely part of a larger Indefinite...